Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls.

Bradley AS, Ford B, Bansal AS.

Clin Exp Immunol. 2013 Apr;172(1):73-80. doi: 10.1111/cei.12043.

2.

Immunological abnormalities in patients with chronic fatigue syndrome.

Tirelli U, Marotta G, Improta S, Pinto A.

Scand J Immunol. 1994 Dec;40(6):601-8.

PMID:
7997849
3.

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.

Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, Garcia-Quintana AM, Castro-Marrero J, Negredo E, Clotet B, Cabrera C, Blanco J.

J Transl Med. 2013 Mar 20;11:68. doi: 10.1186/1479-5876-11-68.

4.

Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

Robertson MJ, Schacterle RS, Mackin GA, Wilson SN, Bloomingdale KL, Ritz J, Komaroff AL.

Clin Exp Immunol. 2005 Aug;141(2):326-32.

5.

Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome.

Prinsen H, de Vries IJ, Torensma R, Pots JM, Mulder SF, van Herpen CM, Elving LD, Bleijenberg G, Stelma FF, van Laarhoven HW.

BMC Immunol. 2012 Dec 17;13:71. doi: 10.1186/1471-2172-13-71.

6.

Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome.

Guenther S, Loebel M, Mooslechner AA, Knops M, Hanitsch LG, Grabowski P, Wittke K, Meisel C, Unterwalder N, Volk HD, Scheibenbogen C.

Hum Immunol. 2015 Oct;76(10):729-35. doi: 10.1016/j.humimm.2015.09.028. Epub 2015 Sep 30.

PMID:
26429318
7.

Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome.

Hanevik K, Kristoffersen EK, Sørnes S, Mørch K, Næss H, Rivenes AC, Bødtker JE, Hausken T, Langeland N.

BMC Infect Dis. 2012 Oct 14;12:258. doi: 10.1186/1471-2334-12-258.

8.

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.

Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM.

J Transl Med. 2012 May 9;10:88. doi: 10.1186/1479-5876-10-88.

9.

Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.

Mensah F, Bansal A, Berkovitz S, Sharma A, Reddy V, Leandro MJ, Cambridge G.

Clin Exp Immunol. 2016 May;184(2):237-47. doi: 10.1111/cei.12749. Epub 2016 Feb 22.

PMID:
26646713
10.

Chronic fatigue syndrome--a controlled cross sectional study.

Rasmussen AK, Nielsen H, Andersen V, Barington T, Bendtzen K, Hansen MB, Nielsen L, Pedersen BK, Wiik A.

J Rheumatol. 1994 Aug;21(8):1527-31.

PMID:
7983659
11.

Predictive immunophenotypes: disease-related profile in chronic fatigue syndrome.

Stewart CC, Cookfair DL, Hovey KM, Wende KE, Bell DS, Warner CL.

Cytometry B Clin Cytom. 2003 May;53(1):26-33.

12.

A comprehensive immunological analysis in chronic fatigue syndrome.

Gupta S, Vayuvegula B.

Scand J Immunol. 1991 Mar;33(3):319-27.

PMID:
1849315
13.
14.

Immunological aspects of chronic fatigue syndrome.

Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G.

Autoimmun Rev. 2009 Feb;8(4):287-91. doi: 10.1016/j.autrev.2008.08.003. Epub 2008 Sep 16. Review.

PMID:
18801465
15.

Lymphocyte phenotype and function in the chronic fatigue syndrome.

Straus SE, Fritz S, Dale JK, Gould B, Strober W.

J Clin Immunol. 1993 Jan;13(1):30-40.

PMID:
8095270
16.
17.

Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome.

Zhang Q, Zhou XD, Denny T, Ottenweller JE, Lange G, LaManca JJ, Lavietes MH, Pollet C, Gause WC, Natelson BH.

Clin Diagn Lab Immunol. 1999 Jan;6(1):6-13.

18.

The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Morris G, Berk M, Galecki P, Maes M.

Mol Neurobiol. 2014 Apr;49(2):741-56. doi: 10.1007/s12035-013-8553-0. Epub 2013 Sep 26. Review.

PMID:
24068616
19.

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.

Fluge Ø, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H, Mella O.

PLoS One. 2011;6(10):e26358. doi: 10.1371/journal.pone.0026358. Epub 2011 Oct 19.

20.

Immunologic abnormalities in chronic fatigue syndrome.

Klimas NG, Salvato FR, Morgan R, Fletcher MA.

J Clin Microbiol. 1990 Jun;28(6):1403-10.

Items per page

Supplemental Content

Write to the Help Desk